Showing results (1-10 of 73) with videos related to
Sort By:
Pageof 8
Annual Review of Pharmacology and Toxicology|March 27, 2001
The clinical pharmacology of L-arginineR H Böger, S M Bode-BögerSeminars in Thrombosis and Hemostasis|December 29, 2000
Asymmetric dimethylarginine, derangements of the endothelial nitric oxide synthase pathway, and cardiovascular diseasesR H Böger, S M Bode-BögerVASA. Zeitschrift Fur Gefasskrankheiten|August 1, 1997
[Endothelial dysfunction in peripheral arterial occlusive disease: from basic research to clinical use]R H Böger, S M Bode-BögerVASA. Zeitschrift Fur Gefasskrankheiten|January 1, 1996
[Restenosis after percutaneous transluminal angioplasty: I. Etiology and clinical significance]H Alfke, R H Böger, S M Bode-BögerVASA. Zeitschrift Fur Gefasskrankheiten|January 1, 1996
[Restenosis after percutaneous transluminal angioplasty: II. Possibilities for pharmacologic intervention]R H Böger, S M Bode-Böger, H AlfkeVASA. Zeitschrift Fur Gefasskrankheiten|January 1, 1996
[Pathogenetic aspects of the L-arginine-NO metabolic pathway in arteriosclerosis and possible therapeutic aspects]R H Böger, S M Bode-Böger, J C FrölichNaunyn-Schmiedeberg'S Archives of Pharmacology|April 1, 1998
Differential inhibition of human platelet aggregation and thromboxane A2 formation by L-arginine in vivo and in vitroS M Bode-Böger, R H Böger, A Galland, et al.Cardiovascular Research|April 1, 1994
Long-term administration of L-arginine, L-NAME, and the exogenous NO donor molsidomine modulates urinary nitrate and cGMP excretion in ratsR H Böger, S M Bode-Böger, U Gerecke, et al.European Journal of Clinical Pharmacology|January 29, 1999
Effects of very low dose and enteric-coated acetylsalicylic acid on prostacyclin and thromboxane formation and on bleeding time in healthy subjectsS M Bode-Böger, R H Böger, M Schubert, et al.Journal of Cardiovascular Risk|August 1, 1994
Exercise increases systemic nitric oxide production in menS M Bode-Böger, R H Böger, E P Schröder, et al.Pageof 8